journal article·2025-09Open access

Localized growth factor delivery from microparticles modulates osteogenic and chondrogenic gene expression in a growth factor-dependent manner in an ex vivo chick embryonic bone model

Hassan Rashidi, Helen C. Cox, Omar Qutachi, Dale Moulding, Lisa J. White, Emma L. Smith, Janos M. Kanczler, Luis Rojo, Michael Rotherham, James R. Henstock, Molly M. Stevens, Alicia J. El Haj, Richard O.C. Oreffo, Kevin M. Shakesheff, Felicity R.A.J. Rose

Acta Biomaterialia· Volume 204

Abstract

Growth factors play a crucial role in regulating various cellular functions, including proliferation and differentiation. Consequently, the biomaterial-based delivery of exogenous growth factors presents a promising strategy in regenerative medicine to manage the healing process and restore tissue function. For effective therapeutic applications, it is essential that these active compounds are precisely targeted to the site of regeneration, with release kinetics that align with the gradual pace of tissue growth. We have developed an ex vivo model utilizing a developing embryonic chick bone, and using PLGA-based microparticles as controlled-release systems, allowing for the investigation of the spatiotemporal effects of growth factor delivery on cell differentiation and tissue formation. Our findings demonstrate that BMP2 and FGF2 can significantly alter cell morphology and zonally pattern collagen deposition within the model, but only when the growth factor presentation rate is carefully regulated. Furthermore, the growth factor-dependent responses observed underscore the potential of this model to explore interactions between cells and the growth factors released from biomaterials in an approach which can be applied to bone tissue engineering. STATEMENT OF SIGNIFICANCE: Current biomaterial-based strategies for bone tissue engineering face critical limitations in mimicking the spatial and temporal dynamics of native tissue development. This study introduces an innovative ex vivo embryonic chick bone model to evaluate localized, sustained growth factor delivery using PLGA microparticles. By precisely controlling the release of BMP2 and FGF2, the research demonstrates growth factor-specific modulation of osteogenic and chondrogenic gene expression and matrix deposition, outcomes that traditional in vitro models fail to capture. This physiologically relevant platform bridges a critical gap between basic in vitro assays and complex in vivo models, offering a powerful, low-cost tool for preclinical screening of regenerative therapies, and advancing the rational design of next-generation bone healing strategies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Periodontal Regeneration and Treatments · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (64)

Show source-provided references
1. Bone tissue engineering: state of the union10.1016/j.drudis.2014.04.010 ↗
2. Bone regeneration: current concepts and future directions10.1186/1741-7015-9-66 ↗
3. Bone defect treatment in regenerative medicine: exploring natural and synthetic Bone substitutes10.3390/ijms26073085 ↗
4. Designing smart biomaterials for tissue engineering10.3390/ijms19010017 ↗
5. Biomaterial delivery of morphogens to mimic the natural healing cascade in bone10.1016/j.addr.2012.05.006 ↗
6. Recent advances in smart stimuli-responsive biomaterials for bone therapeutics and regeneration10.1038/s41413-021-00180-y ↗
7. Advances in growth factor delivery for bone tissue engineering10.3390/ijms22020903 ↗
8. Repair of segmental defects of the Tibia with cancellous bone-grafts augmented with HUMAN-bone morphogenetic protein - a preliminary-report10.1097/00003086-198811000-00034 ↗
9. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goal tibial fracture model10.1359/jbmr.1998.13.9.1483 ↗
10. Bone morphogenetic protein-2 application by a poly(D,L-lactide)-coated interbody cage: in vivo results of a new carrier for growth factors
11. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7)10.3109/08977199609003228 ↗
12. A bone regeneration study: transforming growth factor-beta(1) and its delivery10.1097/00001665-199601000-00010 ↗
13. Combination of bone marrow and TGF-beta 1 augment the healing of critical-sized bone defects10.1021/js9800883 ↗
14. The effect of exogenous transforming growth-factor-Beta-2 on healing fractures in THE rabbit10.1016/8756-3282(95)00085-R ↗
15. Porous tricalcium phosphate and transforming growth factor used for anterior spine surgery10.1007/s005860100325 ↗
16. Effect of platelet-derived growth-factor on tibial osteotomies in rabbits10.1016/8756-3282(94)90709-9 ↗
17. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects10.1359/jbmr.060120 ↗
18. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates10.1002/jor.1100170422 ↗
19. Tissue engineered bone using select growth factors: a comprehensive Review of Animal studies and clinical translation studies in man10.22203/eCM.v028a13 ↗
20. Zhu · Appl. BMP Bone Tissue Eng. Front Bioeng. Biotechnol. · 2022 · 10
21. High-dose bone morphogenetic protein-induced ectopic abdomen bone growth10.1016/j.spinee.2009.10.016 ↗
22. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned10.1016/j.spinee.2011.04.023 ↗
23. Advances in the application of bone morphogenetic proteins and their derived peptides in bone defect repair10.1016/j.compositesb.2023.110805 ↗
24. Novel strategies for spatiotemporal and controlled BMP-2 delivery in bone tissue engineering10.1177/09636897241276733 ↗
25. Designing drug delivery systems for cell therapy10.1038/s44222-024-00214-0 ↗
26. The delivery and activation of growth factors using nanomaterials for bone repair10.3390/pharmaceutics15031017 ↗
27. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments10.1098/rsif.2010.0223 ↗
28. Growth factor-loaded microparticles for tissue engineering: the discrepancies of In vitro characterization assays10.1089/ten.tec.2015.0222 ↗
29. Sequential growth factor delivery from complexed microspheres for bone tissue engineering10.1016/j.biomaterials.2008.07.017 ↗
30. Sequential BMP-2/BMP-7 delivery from polyester nanocapsules10.1002/jbm.a.32520 ↗
31. Mini-bones: miniaturized bone in vitromodels10.1016/j.tibtech.2024.01.004 ↗
32. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration10.1359/JBMR.041226 ↗
33. Bone-on-a-chip: microfluidic technologies and microphysiologic models of bone tissue10.1002/adfm.202006796 ↗
34. A novel approach for studying the temporal modulation of embryonic skeletal development using organotypic bone cultures and microcomputed tomography10.1089/ten.tec.2012.0033 ↗
35. Developmental cues for bone formation from parathyroid hormone and parathyroid hormone-related protein in an ex vivo organotypic culture system of embryonic chick Femora10.1089/ten.tec.2012.0132 ↗
36. Evolving applications of the egg: chorioallantoic membrane assay and ex vivo organotypic culture of materials for bone tissue engineering10.1177/2041731420942734 ↗
37. PLGA-based microparticles for the sustained release of BMP-210.3390/polym3010571 ↗
38. Delivery of definable number of drug or growth factor loaded poly(DL-lactic acid-co-glycolic acid) microparticles within human embryonic stem cell derived aggregates10.1016/j.jconrel.2013.02.029 ↗
39. Recent advances in peptide-loaded PLGA nanocarriers for drug delivery and regenerative medicine10.3390/ph18010127 ↗
40. The periosteal requirement and temporal dynamics of BMP2-induced middle phalanx regeneration in the adult mouse10.1002/reg2.81 ↗
41. Digit Tip regeneration: merging regeneration biology with regenerative medicine10.1002/sctm.17-0236 ↗
42. Progressive development of the rat osteoblast phenotype invitro - reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular-matrix10.1002/jcp.1041430304 ↗
43. Lynch · Exp. Cell Res. · 1995 · 216 · 3510.1006/excr.1995.1005 ↗
44. BMP and ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation10.1242/dev.128.22.4523 ↗
45. Interaction of FGF, lhh/pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation10.1016/S1534-5807(02)00261-7 ↗
46. Tenascin-W inhibits proliferation and differentiation of preosteoblasts during endochondral bone formation10.1016/j.bbrc.2007.03.071 ↗
47. Barley grains for the production of endotoxin-free growth factors10.1016/j.tibtech.2013.06.002 ↗
48. Basic fibroblast growth factor enhances PPAR gamma ligand-induced adipogenesis of mesenchymal stem cells10.1016/j.febslet.2004.10.020 ↗
49. FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state10.1089/ten.2006.12.1405 ↗
50. Endogenous FGF-2 levels impact FGF-2/BMP-2 growth factor delivery dosing in aged murine calvarial bone defects10.1002/jbm.a.37249 ↗
51. BMP-2, VEGF and bFGF synergistically promote the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells10.1007/s10529-012-1084-3 ↗
52. Fibroblast growth Factor-2 and bone morphogenetic Protein-2 have a synergistic stimulatory effect on bone formation in cell cultures from elderly mouse and Human bone
53. Mitogenic and chondrogenic effects of fibroblast growth factor-2 in adipose-derived mesenchymal cells10.1016/j.bbrc.2006.02.171 ↗
54. The effects of 1 alpha, 25-dihydroxyvitamin D-3 and transforming growth Factor-beta 3 on bone development in an ex vivo organotypic culture system of embryonic Chick Femora10.1371/journal.pone.0121653 ↗
55. Evaluation of skeletal tissue repair, part 1: assessment of novel growth-factor-releasing hydrogels in an ex vivo chick femur defect model10.1016/j.actbio.2014.06.011 ↗
56. In vivo analysis of hybrid hydrogels containing dual growth factor combinations, and skeletal stem cells under mechanical stimulation for bone repair10.1016/j.mbm.2024.100096 ↗
57. Considerations of growth factor and material use in bone tissue engineering using biodegradable scaffolds in vitro and in vivo10.1038/s41598-024-75198-3 ↗
58. High-throughput routes to biomaterials discovery10.1021/acs.chemrev.0c01026 ↗
59. Screening as a strategy to drive regenerative medicine research10.1016/j.ymeth.2020.04.004 ↗
60. Bone and joint-on-chip platforms: construction strategies and applications10.1002/smtd.202400436 ↗
61. Next-generation approaches for biomedical materials evaluation: microfluidics and organ-on-a-chip technologies10.1002/adhm.202402611 ↗
62. A review of mathematical modeling of bone remodeling from a systems biology perspective10.3389/fsysb.2024.1368555 ↗
63. Treatment of critical-sized bone defects: clinical and tissue engineering perspectives10.1007/s00590-017-2063-0 ↗
64. In vitro models of bone remodelling and associated disorders10.3389/fbioe.2018.00134 ↗